4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-15-050755
Director sold 40,000 shares at an average $9.70 ($387,808)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BRENNAN MURRAY Director | 2015-06-03 | Sale | −34,163 | $9.72 | $332,064 | 18,337 | D |
| BRENNAN MURRAY Director | 2015-06-04 | Sale | −5,837 | $9.55 | $55,743 | 12,500 | D |
| Open-market sales · 40,000 sh · avg $9.70 · $387,808 | |||||||
Loading xslF345X03/doc4.xml…